Correlation Between Edesa Biotech and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Edesa Biotech and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Quoin Pharmaceuticals.
Diversification Opportunities for Edesa Biotech and Quoin Pharmaceuticals
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edesa and Quoin is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edesa Biotech and Quoin Pharmaceuticals
Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the Quoin Pharmaceuticals. In addition to that, Edesa Biotech is 1.53 times more volatile than Quoin Pharmaceuticals Ltd. It trades about -0.37 of its total potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.5 per unit of volatility. If you would invest 88.00 in Quoin Pharmaceuticals Ltd on August 27, 2024 and sell it today you would lose (28.00) from holding Quoin Pharmaceuticals Ltd or give up 31.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edesa Biotech vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Edesa Biotech |
| Quoin Pharmaceuticals |
Edesa Biotech and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edesa Biotech and Quoin Pharmaceuticals
The main advantage of trading using opposite Edesa Biotech and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Edesa Biotech vs. SAB Biotherapeutics | Edesa Biotech vs. Senti Biosciences | Edesa Biotech vs. Cingulate | Edesa Biotech vs. Neurobo Pharmaceuticals |
| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Neurobo Pharmaceuticals | Quoin Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |